Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.46 USD | +2.10% | +4.29% | -0.68% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 48.23M | Sales 2025 * | 47.83M | Capitalization | 78.68M |
---|---|---|---|---|---|
Net income 2024 * | -53M | Net income 2025 * | -62M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.64 x |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-1.53
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.63% |
Latest transcript on Spero Therapeutics, Inc.
1 day | +2.10% | ||
1 week | +4.29% | ||
Current month | -15.12% | ||
1 month | -15.61% | ||
3 months | -7.01% | ||
6 months | +46.00% | ||
Current year | -0.68% |
Managers | Title | Age | Since |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 21-01-03 |
Ankit Mahadevia
FOU | Founder | 43 | 13-03-31 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 17-06-30 |
John Pottage
BRD | Director/Board Member | 71 | 18-08-13 |
Scott Jackson
BRD | Director/Board Member | 60 | 20-04-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.46 | +2.10% | 165,357 |
24-04-25 | 1.43 | +0.70% | 175,454 |
24-04-24 | 1.42 | -1.05% | 110,042 |
24-04-23 | 1.435 | +2.14% | 123,862 |
24-04-22 | 1.405 | +0.36% | 295,578 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.68% | 77.07M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- SPRO Stock